Patients with a rare blood cancer that has relapsed or become resistant to treatment have shown a high response rate to a ...

India continues to see a steady rise in the incidence of lymphoma, the most common type of blood cancer. But among all the ...

Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best ...

Leukaemia & Lymphoma NI (LLNI) marked its 60th anniversary in style with a Black Tie and Diamonds Gala Ball, celebrating six ...

For patients with relapsed/refractory large B-cell lymphoma (LBCL), the autologous, CD19-directed, 4-1BB chimeric antigen ...

Chair of Tampa Light the Night, Laura Sherman, joins Gayle Guyardo, the host of the global health and wellness show, Bloom, ...

Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, a new study found.

In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community ...

The Leukemia and Lymphoma Society is once again hosting Light The Night to bring light to the darkness of cancer. Last year, ...

Verismo Therapeutics, a clinical-stage CAR-T company developing novel KIR-CAR platform technology, today announced that it ...

An event aimed at spreading light and hope for patients and families dealing with the impacts of blood cancer returns Thursday.The Leukemia & Lymphoma Society's "Light the Night" event will return ...

Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced it will present interim findings from three real-world studies in cutaneous ...